HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet Reduced Length of Hospital Stay for COVID-19 Patients

Masimo SafetyNet is a remote patient management and telehealth solution, that uses tetherless Masimo Radius PPG™ SET® pulse oximetry and a smartphone app to seamlessly transmit continuous home-based patient monitoring data to hospital clinicians.

Nevro Corp Newly Released Clinical Data

D. Keith Grossman, Chairman, CEO and President of Nevro said, "In addition to the strong clinical efficacy for HFX Therapy that has already been shown in our landmark SENZA-PDN trial, these results demonstrate improvement in several important health-related quality of life metrics in patients with PDN."

NeuroVasc Technologies Announces First Patient Treated in Clinical Trial to Evaluate Its Novel Stent-Retriever

This trial will evaluate the safety and efficacy of the NeuroVasc ENVI™-SR, a stent-retriever intended for the treatment of acute ischemic stroke to reduce disability by removing blood clots in patients with stroke due to large vessel occlusion.

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal

Speaking on the news, Dr Ross O’Neill, Founding CEO of Neuromod said, “We’re delighted to announce the publication of positive results from the TENT-A2 clinical trial which show greater improvement in tinnitus symptoms from treatment with Lenire. Tinnitus remains one of the largest unmet clinical needs globally and I’m proud that Neuromod is at the forefront of developing bimodal neuromodulation technology to treat chronic tinnitus.

A Randomized MRI-Based Study Reveals VasQ External Support Promotes More Stable Hemodynamics than Standard AVFs

VasQ External Support, a Laminate Medical Technologies device is implanted around the connection between the vein and artery during the creation of an arteriovenous fistula (AVF) for hemodialysis patients with the intent to provide structural reinforcement and promote a more stable flow profile.

Landmark Study Reveals New Technology from DeBogy Molecular Significantly Reduces the Bacteria and Deadly Infection that Can Occur Following a Surgical Implant

DeBogy Molecular notes the breakthrough technology found to safely reduce dangerous bacterial biofilm on Medical Implants by 99.9%, without the use of antibiotics or toxic chemicals.

CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology

CAPS Medical is conducting revolutionary endoscopic treatment of tumors using non-thermal plasma, suitable for a variety of cancer types.

Envoy Medical Reports FDA Approves Clinical Trial of First Fully Implanted Cochlear Implant

If approved by the FDA, the Acclaim would be the first-of-its-kind cochlear implant designed to be fully implanted and use the ear, rather than a microphone, to pick up sound notes Envoy Medical.

Radicle Science Reports History’s Largest Cannabinoid Trial on Pain Finds Significant Improvement

Radicle Science reports results demonstrated clinically meaningful improvements in pain across the different formulations of CBD and rare cannabinoids studied.